Birla Fertility & IVF reaffirms its commitment to transparent, ethical fertility care with its second centre after Banjara Hills in Gachibowli

▴ Birla Fertlity and IVF
Birla Fertility & IVF, one of India’s fastest-growing fertility networks and part of the multibillion-dollar CKA Birla Group, today reaffirmed its commitment to transparency, ethical practices, and clinical excellence with the launch of its new centre in Gachibowli, Hyderabad.
Hyderabad, November 18, 2025: Birla Fertility & IVF, one of India’s fastest-growing fertility networks and part of the multibillion-dollar CKA Birla Group, today reaffirmed its commitment to transparency, ethical practices, and clinical excellence with the launch of its new centre in Gachibowli, Hyderabad. The announcement was made at a press conference addressed by Mr Abhishek Aggarwal, Chief Executive Officer, Birla Fertility & IVF, along with senior fertility specialists from its Gachibowli and Banjara Hills centres.
Infertility rates are steadily rising across India, with one in six couples facing fertility challenges due to lifestyle changes, stress, and delayed family planning. Birla Fertility & IVF brings a care model built on global clinical standards, advanced technology, and complete cost transparency. The brand already has an established presence across South India through its expanding network in Kerala and Bengaluru, further strengthening its focus on the region with this new centre in Hyderabad.
The new Gachibowli centre is also part of Birla Fertility & IVF’s vision to build a nationwide network of 100 centres in the next couple of years, strengthening access to dependable and ethical fertility care across India.
“Our goal is to make scientific care accessible to patients,” said Mr Abhishek Aggarwal, CEO, Birla Fertility & IVF. “Every procedure we offer is guided by data, delivered by experts, and explained with clarity. We believe transparency is the strongest foundation for trust. Our focus remains on ensuring that clinically reliable, affordable, and accessible reproductive healthcare reaches people wherever they are.”
Key Highlights of Birla Fertility & IVF’s Clinical Framework
  • Globally benchmarked clinical and embryology protocols
  • Advanced laboratory technology for improved precision and outcomes
  • Transparent communication on treatment plans, success rates, and costs
  • Ethical, patient-first care guided by the brand philosophy: All Heart. All Science.
Dr Alimileti Jhansi Rani, Centre Head and Fertility Consultant, Birla Fertility & IVF, Banjara Hills Centre, said, “Many couples still delay seeking fertility help because of confusion or fear around treatment. Our approach is to make every patient feel informed and supported from their very first consultation. We spend time understanding their concerns, guiding them through each step, and helping them make informed decisions without anxiety or doubt. Clear communication, transparency in costs, and evidence-based guidance are central to how we build lasting trust with our patients.”
Dr Spandana Nuthakki, Centre Head, Gachibowli Centre, added, “We are seeing a steady rise in fertility concerns among young couples who are balancing demanding careers and postponing family planning. In areas like Gachibowli, where many professionals work in the IT and corporate sectors, stress and long work hours are common lifestyle factors. We are also seeing growing interest in preventive fertility options such as egg freezing and fertility assessments. At our Gachibowli centre, we combine advanced clinical expertise with a compassionate, transparent approach that helps people plan parenthood on their own terms.”
With its centres in Gachibowli and Banjara Hills, Birla Fertility & IVF offers a complete range of fertility services, including in-vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), frozen embryo transfer (FET), blastocyst culture, male and female infertility treatments, egg freezing and fertility preservation, cancer fertility preservation, and preimplantation genetic testing (PGT). These comprehensive services are supported by advanced laboratory technology, global clinical protocols, and a 100 per cent commitment to transparency and ethical care.
The expansion of Birla Fertility & IVF in Hyderabad builds on the CKA Birla Group’s long-standing association with the city through institutions such as the Birla Mandir, Birla Planetarium, and BirlaNu (formerly HIL Limited). This legacy of trust and progress now extends to healthcare, bringing the Group’s hallmark values of integrity, innovation, and care to reproductive medicine.
With more than 51 centres across India and a growing network of fertility experts, Birla Fertility & IVF continues to make fertility care transparent, ethical, and accessible nationwide.
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026